Trade averts shortage of essential drugs

Wholesalers and retailers decide to stock up those medicines whose prices have been reduced by the DPCO

September 06, 2013 10:37 pm | Updated November 16, 2021 08:24 pm IST - MUMBAI:

Wholesalers and retailers nationwide have decided to stock up those medicines whose prices have been reduced by the Drug Price Control Order (DPCO) 2013.

With the DPCO order threatening to trigger shortage of essential medicines, the move comes as a big relief.

The reduced price saw margins come down for the wholesalers and stockists, and several of them significantly cut their stocks of several medicines on the National List of Essential Medicines (NLEM), including prescription drugs such as cardiac drugs, anti-biotics and pain-killers owing to lower margins on them.

The DPCO came into effect end-July, and notified ceiling prices of over 150 essential drugs out of 348 NLEM that have been brought under it.

“It was decided late on Thursday to stock medicines from manufacturers irrespective of the lower margins for us,” J. S. Shinde, President, All India Organization of Chemists and Druggists (AIOCD), a body representing more than seven lakh pharmaceutical wholesalers and retailers, told The Hindu, adding that it had conveyed to all members to comply.

Mr. Shinde said the impact on retailer’s margins due to reduction in retail price and ceiling price, was 5-6 per cent. “At the wholesale level, the impact was around 2 per cent and at retail level around 4 per cent”.

Every year, the pre-monsoon to post-monsoon period (May to September) sees a spurt in viral infections, which, according to Mr. Shinde, is thrice the level of infections in any other time of the year.

Daara Patel, Secretary-General, Indian Drug Manufacturers’ Association (IDMA), said there would not be any shortage of medicines owing to the lower margins to the trade. “The pharmaceutical industry will take a hit of around Rs.2,000 crore under the new DPCO. But the Drug Controller is fully aware of the situation,and has even given time to manufacturers to comply with the need for new labelling on packaging. Even the Excise Department issued a circular clarifying calculation of new excise duty”.

Mr. Shinde said the NLEM will see trade lose around Rs.2,600 crore per annum adding that the DPCO impacted 22 per cent of the Rs.70,000-crore Indian pharmaceutical sector.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.